Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Tian‐Qiang Song"'
Autor:
Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Bin Xu, Dong Wu, Yuan Ji, Ling-Li Chen, Tian-Qiang Song, Wei Zhang, Zhi-Ming Zeng, Hua-Sheng Huang, Kui Wang, Lan-Qing Huang, Yong-Jun Chen, Yu-Chen Yang, Le-Du Zhou, Guo Long, Hai-Tao Zhao, Yun-Chao Wang, Ning-Ling Ge, Yi Chen, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Pathologic complete response (pCR) following preoperative systemic therapy is associated with improved outcomes after subsequent liver transplant/resection in hepatocellular carcinoma (HCC). However, the relationship between radio
Externí odkaz:
https://doaj.org/article/d2e9b4fdc6104cccbc99fee0b861c2ac
Autor:
Guo‐Ming Shi, Xiao‐Yong Huang, Tian‐Fu Wen, Tian‐Qiang Song, Ming Kuang, Hai‐Bo Mou, Le‐Qun Bao, Hai‐Tao Zhao, Hong Zhao, Xie‐Lin Feng, Bi‐Xiang Zhang, Tao Peng, Yu‐Bao Zhang, Xiang‐Cheng Li, Hong‐Sheng Yu, Yu Cao, Lian‐Xin Liu, Ti Zhang, Wei‐Lin Wang, Jiang‐Hua Ran, Ying‐Bin Liu, Wei Gong, Ming‐Xia Chen, Lian Cao, Yang Luo, Yan Wang, Hui Zhou, Guo‐Huan Yang, Jia Fan, Jian Zhou
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4137-4146 (2023)
Abstract Objective This study evaluated the antitumor activity and safety of pemigatinib in previously treated Chinese patients with advanced cholangiocarcinoma and fibroblast growth factor receptor 2 (FGFR2) fusions or rearrangements. Background Pem
Externí odkaz:
https://doaj.org/article/33db6e2caae9409c859c394540b3696a
Autor:
Ning‐Ning Zhang, Jian Zheng, Ying Wu, Jia‐Yu Lv, Shu‐Wen Zhang, Ya‐Min Zhang, Wen‐Tao Jiang, Tian‐Qiang Song, Victoria Kim, Samer Tohme, Tian Liu, Wei Zhang, Jie Gu, Ze‐Yu Wang, Yu‐Hong Suo, Shuai Wang, Wang Li, Li Zhang, Yan Xie, Yong‐He Zhou, Jian‐Yong Liu, Yi‐Bo Qiu, Zhong‐Yang Shen, Ji‐Hui Hao, David Geller, Wei Lu
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2312-2324 (2023)
Abstract Background Liver transplantation (LT), resection (LR), and ablation (LA) are three curative‐intent treatment options for patients with early hepatocellular carcinoma (HCC). We aimed to develop a prognostic calculator to compare the long‐
Externí odkaz:
https://doaj.org/article/dfd365d6b5a841feb918da5fa0a01eba
Autor:
Bin Xu, Sanyuan Dong, Xue-Li Bai, Tian-Qiang Song, Bo-Heng Zhang, Le-Du Zhou, Yong-Jun Chen, Zhi-Ming Zeng, Kui Wang, Hai-Tao Zhao, Na Lu, Wei Zhang, Xu-Bin Li, Su-Su Zheng, Guo Long, Yu-Chen Yang, Hua-Sheng Huang, Lan-Qing Huang, Yun-Chao Wang, Fei Liang, Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Jian Zhou, Meng-Su Zeng, Jia Fan, Sheng-Xiang Rao, Hui-Chuan Sun
Publikováno v:
Liver Cancer (2022)
Introduction: Lenvatinib plus an anti–PD-1 antibody has shown promising anti-tumor effects in patients with advanced hepatocellular carcinoma (HCC), but with clinical benefit limited to a subset of patients. We developed and validated a radiomic-ba
Externí odkaz:
https://doaj.org/article/8ffc70f4b79c4d9794e9ade6e626e051
Autor:
Shu-Wen Zhang, Ning-Ning Zhang, Wen-Wen Zhu, Tian Liu, Jia-Yu Lv, Wen-Tao Jiang, Ya-Min Zhang, Tian-Qiang Song, Li Zhang, Yan Xie, Yong-He Zhou, Wei Lu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundTreatments for patients with early‐stage hepatocellular carcinoma (HCC) include liver transplantation (LT), liver resection (LR), radiofrequency ablation (RFA), and microwave ablation (MWA), are critical for their long-term survival. Howe
Externí odkaz:
https://doaj.org/article/a2c311d6d9b444da8ded5d714fc27495
Autor:
Hui-Chuan Sun, Lu Xie, Xin-Rong Yang, Wei Li, Jian Yu, Xiao-Dong Zhu, Yong Xia, Ti Zhang, Yang Xu, Bo Hu, Li-Ping Du, Ling-Yao Zeng, Jian Ouyang, Wei Zhang, Tian-Qiang Song, Qiang Li, Ying-Hong Shi, Jian Zhou, Shuang-Jian Qiu, Qian Liu, Yi-Xue Li, Zhao-You Tang, Yu Shyr, Feng Shen, Jia Fan
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 22, Pp 2650-2660 (2017)
Background: For Chinese patients with hepatocellular carcinoma (HCC), surgical resection is the most important treatment to achieve long-term survival for patients with an early-stage tumor, and yet the prognosis after surgery is diverse. We aimed to
Externí odkaz:
https://doaj.org/article/ee49e02b78cb40b3853111cc0ae34bd9
Autor:
Guo‐Ming Shi, Xiao‐Yong Huang, Tian‐Fu Wen, Tian‐Qiang Song, Ming Kuang, Hai‐Bo Mou, Le‐Qun Bao, Hai‐Tao Zhao, Hong Zhao, Xie‐Lin Feng, Bi‐Xiang Zhang, Tao Peng, Yu‐Bao Zhang, Xiang‐Cheng Li, Hong‐Sheng Yu, Yu Cao, Lian‐Xin Liu, Ti Zhang, Wei‐Lin Wang, Jiang‐Hua Ran, Ying‐Bin Liu, Wei Gong, Ming‐Xia Chen, Lian Cao, Yang Luo, Yan Wang, Hui Zhou, Guo‐Huan Yang, Jia Fan, Jian Zhou
Publikováno v:
Cancer Medicine. 12:4137-4146
This study evaluated the antitumor activity and safety of pemigatinib in previously treated Chinese patients with advanced cholangiocarcinoma and fibroblast growth factor receptor 2 (FGFR2) fusions or rearrangements.Pemigatinib provided clinical bene
Autor:
Ning‐Ning Zhang, Jian Zheng, Ying Wu, Jia‐Yu Lv, Shu‐Wen Zhang, Ya‐Min Zhang, Wen‐Tao Jiang, Tian‐Qiang Song, Victoria Kim, Samer Tohme, Tian Liu, Wei Zhang, Jie Gu, Ze‐Yu Wang, Yu‐Hong Suo, Shuai Wang, Wang Li, Li Zhang, Yan Xie, Yong‐He Zhou, Jian‐Yong Liu, Yi‐Bo Qiu, Zhong‐Yang Shen, Ji‐Hui Hao, David Geller, Wei Lu
Publikováno v:
Cancer Medicine. 12:2312-2324
Liver transplantation (LT), resection (LR), and ablation (LA) are three curative-intent treatment options for patients with early hepatocellular carcinoma (HCC). We aimed to develop a prognostic calculator to compare the long-term outcomes following
Autor:
Zhu-Qing Shao, Wei Wang, Shouzhou Zhang, Liangsheng Zhang, Yves Van de Peer, Ming‐Qiang Wang, Yongxia Zhang, Guang-Can Zhou, Yan-Mei Zhang, Cymon J. Cox, Hong-Feng Chen, Fei Chen, Min Chen, Zhen Li, Shan-Shan Dong, Yue-Yu Hang, Xiao-Qin Sun, Tian‐Qiang Song, Jia-Yu Xue, Yang Liu, Qiang Wang
Publikováno v:
JOURNAL OF SYSTEMATICS AND EVOLUTION
The early diversification of angiosperms is thought to have been a rapid process, which may complicate phylogenetic analyses of early angiosperm relationships. Plastid and nuclear phylogenomic studies have raised several conflicting hypotheses regard
Autor:
Hong-feng Yuan, Man Zhao, Li-na Zhao, Hao-lin Yun, Guang Yang, Yu Geng, Yu-fei Wang, Wei Zheng, Ying Yuan, Tian-qiang Song, Jun-qi Niu, Xiao-dong Zhang
Publikováno v:
Acta pharmacologica Sinica. 43(9)
The protein arginine methyltransferase 5 (PRMT5), which is highly expressed in tumour tissues, plays a crucial role in cancer development. However, the mechanism by which PRMT5 promotes cancer growth is poorly understood. Here, we report that PRMT5 c